{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:46:35Z","timestamp":1792039595065,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,19]],"date-time":"2027-09-19T00:00:00Z","timestamp":1821312000000},"content-version":"am","delay-in-days":322,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.lungcan.2026.109626","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:37:42Z","timestamp":1789688262000},"page":"109626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Change in the incidence of medication-related osteonecrosis of the jaw in lung cancer patients receiving bone modifying agents with immune checkpoint inhibitors"],"prefix":"10.1016","volume":"221","author":[{"given":"Ayaka","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakim Ali","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4927-1368","authenticated-orcid":false,"given":"Kaoru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0206-7871","authenticated-orcid":false,"given":"Yuko","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miku","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2293-350X","authenticated-orcid":false,"given":"Yuto","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisatoshi","family":"Yamao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3694-2556","authenticated-orcid":false,"given":"Sanae","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6250-0412","authenticated-orcid":false,"given":"Takeshi","family":"Shimoide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4347-8106","authenticated-orcid":false,"given":"Atsushi-Doksa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5804-8283","authenticated-orcid":false,"given":"Akifumi","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.lungcan.2026.109626_b0005","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109626_b0010","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.lungcan.2026.109626_b0015","unstructured":"H. Kishimoto, H. Hagino, Y. Kitagawa, T. Nomura, S. Arai, H. Kurita, M. Umeda, D. Inoue, A. Taguchi, T. Ikeda, T. Taguchi, H. Harada, Pathology and management for medication-related osteonecrosis of the jaw: Position Paper by the Japanese Allied Committee on medication-related osteonecrosis of the jaw - 2023 update, (2023)."},{"key":"10.1016\/j.lungcan.2026.109626_b0020","doi-asserted-by":"crossref","unstructured":"J. Japanese Allied Committee on Osteonecrosis of the, T. Yoneda, H. Hagino, T. Sugimoto, H. Ohta, S. Takahashi, S. Soen, A. Taguchi, T. Nagata, M. Urade, T. Shibahara, S. Toyosawa, Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw, J Bone Miner Metab 35(1) (2017) 6-19.","DOI":"10.1007\/s00774-016-0810-7"},{"issue":"7","key":"10.1016\/j.lungcan.2026.109626_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201343","article-title":"Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: is tooth extraction a risk factor?","volume":"13","author":"Soutome","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109626_b0030","first-page":"1","article-title":"Cancer patients receiving bone-modifying agents show different rates of anti-resorptive agent-related osteonecrosis of the jaw depending on their primary disease","volume":"17","author":"Enomoto","year":"2018","journal-title":"Oral Health Dent Manag"},{"issue":"5","key":"10.1016\/j.lungcan.2026.109626_b0035","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s10147-019-01548-1","article-title":"Combination therapy with PD-1 or PD-L1 inhibitors for cancer","volume":"25","author":"Hayashi","year":"2020","journal-title":"Int. J. Clin. Oncol."},{"issue":"21","key":"10.1016\/j.lungcan.2026.109626_b0040","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1200\/JCO.21.00174","article-title":"Five-year outcomes with pembrolizumab versus chemotherapy for metastatic non-small-cell lung cancer with PD-L1 tumor proportion score >\/= 50","volume":"39","author":"Reck","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109626_b0045","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American association of oral and maxillofacial surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"8 Suppl","key":"10.1016\/j.lungcan.2026.109626_b0050","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2026.109626_b0055","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ctrv.2011.06.011","article-title":"Skeletal metastasis in renal cell carcinoma: current and future management options","volume":"38","author":"Wood","year":"2012","journal-title":"Cancer Treat. Rev."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109626_b0060","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2026.109626_b0065","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/j.joms.2011.03.051","article-title":"Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan","volume":"69","author":"Urade","year":"2011","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109626_b0070","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/0976-237X.107424","article-title":"Tooth loss, chewing ability and quality of life","volume":"3","author":"Bortoluzzi","year":"2012","journal-title":"Contemp Clin Dent"},{"key":"10.1016\/j.lungcan.2026.109626_b0075","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1186\/1471-2458-12-839","article-title":"The impact of having natural teeth on the QoL of frail dentulous older people. a qualitative study","volume":"12","author":"Niesten","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.lungcan.2026.109626_b0080","doi-asserted-by":"crossref","unstructured":"D.S. Ettinger, D.E. Wood, D.L. Aisner, W. Akerley, J. Bauman, L.R. Chirieac, T.A. D'Amico, M.M. DeCamp, T.J. Dilling, M. Dobelbower, R.C. Doebele, R. Govindan, M.A. Gubens, M. Hennon, L. Horn, R. Komaki, R.P. Lackner, M. Lanuti, T.A. Leal, L.J. Leisch, R. Lilenbaum, J. Lin, B.W. Loo, Jr., R. Martins, G.A. Otterson, K. Reckamp, G.J. Riely, S.E. Schild, T.A. Shapiro, J. Stevenson, S.J. Swanson, K. Tauer, S.C. Yang, K. Gregory, M. Hughes, Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology, J Natl Compr Canc Netw 15(4) (2017) 504-535.","DOI":"10.6004\/jnccn.2017.0050"},{"issue":"30","key":"10.1016\/j.lungcan.2026.109626_b0085","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1200\/JCO.2017.74.6065","article-title":"Systemic therapy for stage IV non-small-cell lung cancer: american society of clinical oncology clinical practice guideline update","volume":"35","author":"Hanna","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109626_b0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.9702","article-title":"Comparison of survival rates after a combination of local treatment and systemic therapy vs systemic therapy alone for treatment of stage IV non-small cell lung cancer","volume":"2","author":"Uhlig","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109626_b0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12903-019-0869-3","article-title":"Relationship between the state of tongue hygiene and the number of residual teeth in convalescent-ward inpatients, cross- sectional study","volume":"19","author":"Hayashi","year":"2019","journal-title":"BMC Oral Health"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109626_b0100","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1186\/s12877-022-03541-2","article-title":"Association between the number of remaining teeth and disability-free life expectancy, and the impact of oral self-care in older Japanese adults: a prospective cohort study","volume":"22","author":"Yamato","year":"2022","journal-title":"BMC Geriatr."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109626_b0105","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/ajco.13395","article-title":"Single-center analysis of antiresorptive agent-related osteonecrosis of the jaw in lung cancer patients","volume":"16","author":"Okamura","year":"2020","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109626_b0110","doi-asserted-by":"crossref","first-page":"E970","DOI":"10.1073\/pnas.1616848114","article-title":"Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis","volume":"114","author":"Zhang","year":"2017","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109626_b0115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.lungcan.2026.109626_b0120","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2217\/imt-2020-0108","article-title":"Osteonecrosis of the jaw induced by treatment with anti-PD-1 immunotherapy: a case report","volume":"12","author":"Pundole","year":"2020","journal-title":"Immunotherapy"},{"key":"10.1016\/j.lungcan.2026.109626_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.837645","article-title":"The role of immune checkpoint molecules on macrophages in cancer, infection, and autoimmune pathologies","volume":"13","author":"Brom","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109626_b0130","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1186\/s12967-023-04482-z","article-title":"Osteonecrosis of the jaw induced by immune checkpoint inhibitors: an urgent need for attention","volume":"21","author":"Li","year":"2023","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109626_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14020330","article-title":"Macrophage involvement in medication-related osteonecrosis of the jaw (MRONJ): a comprehensive, short review","volume":"14","author":"Gkouveris","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109626_b0140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.36401\/JIPO-23-14","article-title":"Oral toxicities associated with immune checkpoint inhibitors: meta-analyses of clinical trials","volume":"7","author":"Srivastava","year":"2024","journal-title":"J. Immunother. Precis. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109626_b0145","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4103\/apjon.apjon-2136","article-title":"Oral immune-related adverse events - current concepts and their management","volume":"8","author":"Asan","year":"2021","journal-title":"Asia Pac. J. Oncol. Nurs."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109626_b0150","first-page":"2341","article-title":"Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score-matched analysis","volume":"30","author":"Ikesue","year":"2022","journal-title":"Support Care Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:07:39Z","timestamp":1792037259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226006872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":30,"alternative-id":["S0169500226006872"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109626","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Change in the incidence of medication-related osteonecrosis of the jaw in lung cancer patients receiving bone modifying agents with immune checkpoint inhibitors","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109626"}}